References
Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Shukla SY, Reily B, Shields J (2013) Retinal vasoproliferative tumors. Comparative clinical features of primary vs secondary tumors in 334 cases. JAMA Ophthalmol 131:328–334
Kaly L, Rosner I (2012) Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases. Best Pract Res Clin Rheumatol 26:157–165
Hoeve M, Kalinina Ayuso V, Schalij-Delfos NE, Los LI, Rothova A, de Boer JH (2012) The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol 96:852–856
Heimann H, Bornfeld N, Vij O, Coupland SE, Bechrakis NE, Kellner U, Foerster MH (2000) Vasoproliferative tumours of the retina. Br J Ophthalmol 84:1162–1169
Irvine F, O’Donnell N, Kemp E, Lee WR (2000) Retinal vasoproliferative tumors: surgical management and histological findings. Arch Ophthalmol 118:563–569
Adán A, Mesquida M, Llorenç V, Espinosa G, Molins B, Hernandez MV, Pelegrín L (2013) Tocilizumab treatment for refractory uveitis-related cystoid macular edema. Graefes Arch Clin Exp Ophthalmol
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adán, A., Mesquida, M., Llorenç, V. et al. Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case report. Graefes Arch Clin Exp Ophthalmol 252, 163–164 (2014). https://doi.org/10.1007/s00417-013-2466-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2466-5